Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

The Role of Trivalent Chromium as a Supplement

3가 크롬의 보조제로서의 역할

  • Published : 2004.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Chromium has been known to be involved in the glucose metabolism, and hence the utilization of cellular glucose is impaired in the chromium deficiency. Chromium has been recognized as an essential nutrient since the finding of low-molecular-weight Cr-binding substance (LMWCr) as a biological modifier of insulin action. Clinical chromium deficiency associated with glucose intolerance that respond to the administration of chromium. The major impediment to the use of orally administered chromium is poor absorption of trivalent chromium in its inorganic form. Trivalent chromium is more available in yeast md, more recently, as chromium picolinate for oral absorption. The widespread use of these supplements has resulted in controversy regarding chromium's role as a nutrient, its use for treatment of insulin resistance, and its potential toxicity. Most recent evidence strongly supports tile conclusion that there is little fear of toxic reactions from chromium consumption. This report reviews the evidence for the potential toxicity of chromium supplements in contrast with its usefulness as a nutrient or therapeutic agent in the treatment or prevention of insulin resistance.

인슐린 작용을 강화시키는 LMWCr의 발견과 크롬 결핍과 관련 있는 포도당 불내성(glucose intolerance)이 크롬 투여 시 반응을 보여준 임상적 증명 이후, 크롬은 확실한 필수 영양소로 인식되고 보조제로 사용되고 있다. 시험관 실험에서 고농도의 3가 크롬을 배양 세포에 노출 시, 일부 연구 결과에서 염색체이상 유발과 변이원성 효과가 발견되긴 하였으나 이는 비타민 A, D, 니코틴산, 셀레늄 등과 같은 많은 다른 영양소의 과잉 섭취 시 독성 효과를 나타내는 정도로 해석되며, 시험관 실험 결과들이 발암성의 증거로 해석되지는 않는다. 3가 크롬을 경구 보조제로 투여된 임상 치료에서 환자들은 독성효과를 보이지 않았으며, 혈장 내 크롬 수치가 비 투여된 사람들에 비하여 조금 높았다. 크롬을 TPN 형태로 투여받은 환자들에게서도 우려했던 신체ㆍ정신적 효과와의 상관 관계가 없었으며 신기능부전을 나타낸 경우는 신장 독성을 주는 약들을 함께 복용한 경우로서, 우려되는 부작용은 없는 것으로 인정된다. 임상학적, 실험적으로 사용된 3가 크롬의 용량은 ESADDI 규정된 범위 50∼200 $\mu$g/day에서 전혀 독성을 나타내지 않았으며, 일반적인 사용에 기준이 될 것이다. EPA는 모든 관련 자료들을 검토한 후에 크롬의 참고용량 (RfD) 수치를 70 mg/day로 결론지었으며, 다른 영양소들의 용량과 비교했을 때 대단히 넓은 수치이다. 3가 크롬은 당뇨병, 임신성 당뇨병, 인슐린 내성, 비정상적 지방대사를 개선시키기 위한 영양소로서 가능성을 가진다. 또한 크롬의 보충은 제II형 당뇨병과 다양한 심혈관계 질환을 예방하거나 치료하는데 가장 유용한 것으로 밝혀졌다. 앞으로는 크롬 보조제 사용 시, 일부 연구자들이 3가 크롬 1000 $\mu$g/day의 안전성을 입증한 것과 같이 용량을 늘려 임상실험을 시도한 후 안전과 효능을 증명하는 것이 필요하다.

Keywords

References

  1. J Agric Food Chem v.43 Phenol antioxidant index: comparative antioxidant effectiveness of red and white wines Vinson,J.A.;Hontz,B.A. https://doi.org/10.1021/jf00050a027
  2. Clin Sci v.91 Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro, identification and mechanism of action of some cinnamic acid derivatives from red wine Abu Amsha,R.;Croft,K.D.;Puddey,I.B.;Beilin,L.J.
  3. J Sci Food Agric v.79 Electron spin resonance (ESR0 spectroscopic assessment of the contribution of quercetin and other flavonols to the antioxidative capacity of red wines Gardner,P.T.;Mcphail,D.B.;Grozier,A.;Duthie,G.G. https://doi.org/10.1002/(SICI)1097-0010(19990515)79:7<1011::AID-JSFA320>3.0.CO;2-Y
  4. J Agric Food Chem v.46 Antioxidantc activity of berry and fruit wines and liquors Heinonen,I.M.;Lehtonen,P.J.;Hopia,A.I. https://doi.org/10.1021/jf970489o
  5. Lipids v.34 Antioxidant and other activities of phenolics in olives/olive oil, typical components of the Mediterranean diet Galli,C.;Visioli,F. https://doi.org/10.1007/s11745-999-333-4
  6. J Am Oil Sci v.62 Antioxidants in clove Kramer,S.E. https://doi.org/10.1007/BF02541505
  7. Food Res v.17 The antioxidant properties of natural spices Chipault,J.R.;Mizuno,G.R.;Hawkins,J.M.;Lundberg,W.O. https://doi.org/10.1016/0165-1218(86)90095-9
  8. J Korean Soc Food Nutr v.23 The effect of hot water extract and flavor compounds of mugwort on microbial growth Kim,Y.S.;Kim,M,N,;Kim,J.O.;Lee,J.H.
  9. Korean J Food Sci Technol v.26 Antimicrobial effect of each solvent fraction of morus alba linne, sopora flavescens altom on Listeria monycytogenes Han,J.S.;Shin,D.H.
  10. Korean J Food Sci Technol v.25 Antioxidantive effects of volatile oil and oleoresin extracted from rosemary, sage, clove and nutmeg Lee,Y.C.;Yoon,J.H.
  11. Korean J Food Sci Technol v.32 Antioxidant and mixture effects of curry spices extracts obtained by solvent extraction Ahn,C.K.;Lee,Y.C.;Yeom,C.A.
  12. Official methods of analysis (15th ed.) AOAC https://doi.org/10.1021/tx970010m
  13. JAOCS v.72 Separation and indentification of eugenol in ethanol extract of cloves by reversed-phase high-performance liquid chromatography Myint,S.;Ramli,W.;Daud,W.;Mohamad,A.B.;Amir,A.;Kadhum,H. https://doi.org/10.1016/0013-9351(83)90210-4
  14. Official methods of analysis (15th ed.) AOAC https://doi.org/10.1016/0162-0134(84)80018-5
  15. Japan Oil Chemists' Society 2.4 Standard methods for the analysis of fats, oils and related materials JOCS https://doi.org/10.1016/0891-5849(94)00159-H
  16. Nature v.26 Antioxidant determmation by the use of a stable free radical Blois,M.S.
  17. Natural product chemistry method (2nd ed.) Phenolic compound Woo,W.S. https://doi.org/10.1016/0048-9697(88)90237-9
  18. Bull Korean Fish Soc v.19 Antioxidative effect of ginger extracts on fish oil Byun,H.S.;Kim,S.B.;Park,Y.H.
  19. Kor J Food Hygiene v.7 Studies on the effect of the extract of eugenia flos on gastrins and gastric lesion Jung,K.H.;Lee,E.B. https://doi.org/10.1016/0006-291X(89)92119-0
  20. Korean J Food Technol v.35 Physiological activities of commercial instant curry powers and individual apices Chung,M.S.;Jung,S.H.;Lee,J.S.;Park,J.L. https://doi.org/10.1021/bi963154t
  21. Fleischwirtschaft v.49 Effect of natural spices, spice extracts essential oils extraction residues, and suthetic antioxidants on the decomposition of pork fat and model lipids I. Effect of natural spices and spice extracts on pork fat Palitzch,A.;Schulte,H.;Metzl,F.;Baas,H.
  22. J Food Process Preserv v.1 Antioxidant effect od spices, herbs and protein hydrolyzates in freezedried model system: synergistic action with synthetic phenolic antioxidant Bishov,S.J.;Masuoka,Y.;Kapsalis,J.G. https://doi.org/10.1111/j.1745-4549.1977.tb00320.x
  23. David CM, Vincent JB. 1997. Chromiun oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36: 4382-4385 https://doi.org/10.1021/bi963154t
  24. Costa M. 1997. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. CRC Crit Revie Toxicol 27: 431-442 https://doi.org/10.3109/10408449709078442
  25. Shi X, Mao Y, Knapton AD, Ding M, Rojanasakul Y, Gannett PM, Dalal NS, Liu K. 1994. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of Cr(IV)-mediated Fenton-like reaction. Carcinogenesis 15: 2475-2478 https://doi.org/10.1093/carcin/15.11.2475
  26. Dizadaroglu M. 1991. Chemical determination of free radical-induced damage to DNA. Free Radical Biol Med 10: 225-242 https://doi.org/10.1016/0891-5849(91)90080-M
  27. Brambilla G, Martelli A, marinari UM. 1989. Is lipid peroxidation associated with DNA damage? Mutat Res 214: 123-127 https://doi.org/10.1016/0027-5107(89)90205-4
  28. Ye J, Zhang X, Young HA, Shi X. 1995. Chromium (VI)-induced nuclear factor- ${\kappa}$B activation in intact cells via free radical reactions. Carcinogenesis 16: 2401-2405 https://doi.org/10.1093/carcin/16.10.2401
  29. Bagchi D, Bagchi M, Balmoori J, Ye X. 1997. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res Commun Mol Pathol Pharmacol 97: 335-346
  30. Ryberg D, Alexander J. 1990. Mechanisms of chromium toxicity in mitochondria. Chem Biol Interact 75: 141-145 https://doi.org/10.1016/0009-2797(90)90114-3
  31. De Flora S, Bagnasco M, Serra D, Zanacchi P. 1990. Genotoxicity of chromium compounds. A review. Mutat Res 238: 99-172 https://doi.org/10.1016/0165-1110(90)90007-X
  32. Danielsson BR, Dencker L, Khayat A, Orsen I. 1982. Embryotoxicity of chromium: distribution in pregnant mice and effect on embryonnic cells in vitro. Arch Toxicol 51: 233-245
  33. Endo A, Watanabe T. 1988. Analysis of protective activity of N-acetylcysteine against teratogenicity of heavy metals. Reprod Toxicol 6: 9-19 https://doi.org/10.1016/0890-6238(92)90017-N
  34. Ueno S, Susa N, Furukawa Y. 1990. Uptake and distribution of chromium in isolated rat hepatocytes and its relation to cellular injury. Kiasato Arch Exp Med 63: 49-57
  35. Rajaram R, Nair BU, Ramasami T. 1995. Chromium (III) induced abnormalities in human lymphocyte cell proliferation: evidence for apoptosis. Biochem Biophys Res Commun 210: 434-440 https://doi.org/10.1006/bbrc.1995.1679
  36. Ivankovic S, Preussmann R. 1975. Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term feeding experiments in rats. Food Cosmet Toxicol 13: 347-351 https://doi.org/10.1016/S0015-6264(75)80298-7
  37. Stearns DM, Wise JP Sr, Patierno SR, Wetterhahn KE. 1995. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovarian cells. FASER J 9: 1643-1648
  38. Jeejeebhoy KN. 1999. Chromium and parenteral nutrition. J Trace Elem Exp Med 12: 85-90 https://doi.org/10.1002/(SICI)1520-670X(1999)12:2<85::AID-JTRA5>3.0.CO;2-Z
  39. Hathcock JN. 1996. Safety limits for nutrients. J Nutr 126 (suppl): 2386-2389
  40. Anderson RA. 1997. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 26(suppl): 35-41 https://doi.org/10.1006/rtph.1997.1136
  41. Offenbacher EG, Pi-Sunyer FX. 1980. Beneficial effects of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29: 919-925 https://doi.org/10.2337/diabetes.29.11.919
  42. Anderson RA. 1994. Stress effets on chromium nutrition of humans and animals. In Biotechnology in the Feed Industry. Proc Alltech Annu Spymp 10th Nottingham Univ Press, Nottingham, England. p 267-274
  43. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N. 1997. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46: 1786-1791 https://doi.org/10.2337/diabetes.46.11.1786
  44. Burton JL, Nonnecke BJ, Dubeski PL, Elasser TH, Mallard BA. 1996. Effects of supplemental chromium on production of cytokines by mitogon-stimulated bovine peripheral bood mononucleal cells. J Dairy Sci 79: 2237-2246 https://doi.org/10.3168/jds.S0022-0302(96)76600-6
  45. Kegley EB, Spears JW, Brown TT Jr. 1997. Effect of shipping and chromium supplementation on performance response, and disease resistance in steers. J Anim Sci 75: 1956-1964
  46. Lovrincevic I, Leung FY, Alfieri MAH, Grace DM. 1996. Can elevated chromium induce somatopsychic responses? Biol Trace Elem Res 55: l63-17l https://doi.org/10.1007/BF02784177
  47. Schrauzer GH, Shrestha KP, Arce MF. 1992. Somatopsychological effects of chromium supplementation. J Nutr Med 3: 43-48 https://doi.org/10.3109/13590849208997960
  48. Wasser WG, Feldman NS, D'Agati VD. 1997. Chronic renal failure after ingestion of over-the-counter chromium picolinate [letter]. Ann Intern Med 126: 410
  49. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. 1998. Chromium picolinate toxicity. Ann Pharmacother 32: 428-43l https://doi.org/10.1345/aph.17327
  50. Hathcock JN. 1997. Vitamins and minerals: efficacy and safety. Am J Clin Nutr 66: 427-437